Management of dental patients who are HIV-positive: Antifungal treatments

This is the second in a series of systematic reviews of critical oral health care issues collaboratively supported by the National Institute of Dental and Craniofacial Research (NIDCR) and the Agency for Healthcare Research and Quality (AHRQ). Rather than focusing on a specific dental disease condition or a particular treatment approach, this report focuses on several aspects of the dental management of a special population subgroup-the estimated 900,000 persons in the United States infected with the human immunodeficiency virus (HIV) or living with the acquired immune deficiency syndrome (AIDS). These aspects include: Complications associated with invasive dental treatments. Dental conditions as markers or indicators of change in HIV serostatus and immunosuppression. The efficacy or effectiveness of available antifungal drugs to prevent or treat oral candidiasis. This report was prepared to serve as a major element of a State of the Science Workshop that NIDCR held in December 2000 on the management of dental patients with HIV/AIDS.

• Population(s)
  • General HIV- population
• Engagement and Care Cascade
  • Treatment
• Co-morbidities
  • Other